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Abstract
Background: Overweight and obesity are highly prevalent among persons with serious mental illness. These
conditions likely contribute to premature cardiovascular disease and a 20 to 30 percent shortened life expectancy
in this vulnerable population. Persons with serious mental illness need effective, appropriately tailored behavioral
interventions to achieve and maintain weight loss. Psychiatric rehabilitation day programs provide logical
intervention settings because mental health consumers often attend regularly and exercise can take place on-site.
This paper describes the Randomized Trial of Achieving Healthy Lifestyles in Psychiatric Rehabilitation (ACHIEVE).
The goal of the study is to determine the effectiveness of a behavioral weight loss intervention among persons
with serious mental illness that attend psychiatric rehabilitation programs. Participants randomized to the
intervention arm of the study are hypothesized to have greater weight loss than the control group.
Methods/Design: A targeted 320 men and women with serious mental illness and overweight or obesity (body
mass index ≥ 25.0 kg/m
2) will be recruited from 10 psychiatric rehabilitation programs across Maryland. The core
design is a randomized, two-arm, parallel, multi-site clinical trial to compare the effectiveness of an 18-month
behavioral weight loss intervention to usual care. Active intervention participants receive weight management
sessions and physical activity classes on-site led by study interventionists. The intervention incorporates cognitive
adaptations for persons with serious mental illness attending psychiatric rehabilitation programs. The initial
intensive intervention period is six months, followed by a twelve-month maintenance period in which trained
rehabilitation program staff assume responsibility for delivering parts of the intervention. Primary outcomes are
weight loss at six and 18 months.
Discussion: Evidence-based approaches to the high burden of obesity and cardiovascular disease risk in person
with serious mental illness are urgently needed. The ACHIEVE Trial is tailored to persons with serious mental illness
in community settings. This multi-site randomized clinical trial will provide a rigorous evaluation of a practical
behavioral intervention designed to accomplish and sustain weight loss in persons with serious mental illness.
Trial Registration: Clinical Trials.gov NCT00902694
Background
The prevalence of overweight and obesity has signifi-
cantly increased over the past several decades with
roughly 34% of U.S. adults currently being obese [1,2]. In
persons with serious mental illness (e.g., schizophrenia,
bipolar disorder), overweight and obesity are at epidemic
levels that are higher than in the overall U.S. population
[3-5]. Obesity significantly increases the risk of morbidity
and mortality from cardiovascular disease mainly through
the effects of obesity on hypertension, hyperlipidemia and
diabetes mellitus [6,7]. Furthermore, many classes of psy-
chotropic drugs are associated with weight gain. [3,8,9].
Given the long-term needs of most patients with serious
mental illness to continue psychotropic medications,
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are urgently needed.
National guidelines for weight loss emphasize a multi-
faceted approach to include reduced energy intake,
improved dietary patterns and increased physical activity
[10-13]. Randomized controlled behavioral weight loss
intervention trials showing efficacy for weight loss in the
general population have systematically excluded indivi-
duals with chronic mental illness from participating
[14-19]. In addition, behavioral lifestyle interventions in
persons with serious mental illness pose several chal-
lenges since these individuals may have competing
demands on a daily basis. Person with serious mental ill-
ness are often dealing with active mental health symp-
toms, housing issues, substance abuse or other social
issues that may take precedence over behavioral change
for weight loss. Furthermore, the high prevalence of
cognitive deficits in this population can impede indivi-
duals from successfully performing activities of daily liv-
ing [20]. Thus, traditional behavioral interventions that
have been shown to be effective in populations without
mental illness should be tailored to meet the specific
needs of persons with serious mental illness [14].
There have been few behavioral interventions that
have targeted weight loss in persons with serious mental
illness. Most previous studies have applied strategies
similar to those used in trials for the general population
and have focused exclusively on dietary intake with a
few incorporating some physical activity component.
Furthermore, the interventions in this population have
been small (< 60 participants), without a control com-
parison group and have used various methods to induce
behavior change [21-28]. Nevertheless, the literature
indicates that selected persons with serious mental ill-
ness can benefit from short-term behavioral weight loss
interventions [17]. Given the health benefits of exercise
and healthy dietary patterns, randomized controlled
trials of comprehensive weight loss interventions (diet-
ary and physical activity components) are needed among
persons with serious mental illness.
This protocol describes a randomized, controlled trial of
a comprehensive behavioral weight loss and weight main-
tenance program among persons with serious mental ill-
ness that attend psychiatric rehabilitation day programs
across Maryland. Psychiatric rehabilitation programs
(PRP) are outpatient facilities where persons with serious
mental illness attend up to several days a week and receive
vocational and other services. Psychiatric rehabilitation
programs may be opportune and efficient settings for test-
ing, implementing and disseminating interventions. Reha-
bilitation programs have classroom and communal space
suitable for group weight management and exercise ses-
sions. The potential sustainability of a weight loss inter-
vention at psychiatric rehabilitation programs may be
more feasible than in other types of mental health settings
because consumers regularly attend and the centers
already offer other types of classes. In addition, most reha-
bilitation programs serve persons with a range of serious
mental illness diagnoses, including schizophrenia; thus,
interventions targeted to these settings could generalize to
broad populations with serious mental illness.
Methods
Study Design Summary
The core design is a randomized, two-arm, parallel,
multi-site clinical trial. Inclusion/exclusion criteria were
chosen to enroll a population with chronic mental ill-
ness who are overweight or obese and who may safely
participate in a weight loss intervention including mod-
erate intensity exercise. Interested mental health consu-
mers are being screened for eligibility at 10 psychiatric
rehabilitation centers across Maryland. Three hundred
and twenty adult participants completing screening are
targeted for enrollment and randomization to the
ACHIEVE (Achieving Healthy Lifestyles in Psychiatric
Rehabilitation) intervention or usual care. Intervention
participants receive group and individual weight man-
agement sessions and group physical activity classes. In
the initial 6-month intervention phase, study interven-
tionists lead the sessions and also train designated reha-
bilitation program staff. A 12-month maintenance
intervention phase follows in which interventionists con-
tinue leading some sessions and trained rehabilitation
staff assume responsibility for delivering part of the
intervention. Interventionists also provide education to
rehabilitation program kitchen staff to increase options
for healthy meals served on-site. Follow-up data collec-
tion occurs at 6, 12, and 18 months from baseline. The
study was approved by the Johns Hopkins Institutional
Review Board (protocol number NA00015231).
Specific Aims
Primary Aim
Determine the effect of the ACHIEVE intervention on
weight loss at 6 and 18 months. The hypothesis is that
the ACHIEVE intervention group will have greater
weight loss than the control group.
Secondary Aims
Determine the effect of the ACHIEVE intervention on
the following outcomes at 6 and 18 months: physical fit-
ness by submaximal bicycle ergometer; waist circumfer-
ence; blood pressure; lipids; Framingham cardiovascular
risk score; health status with SF-12 and depression with
CES-D. The hypothesis is that the ACHIEVE interven-
tion group will have greater improvement of these out-
comes compared to the control group. In addition, costs
per participant will be assessed and a cost effectiveness
analysis will be performed.
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The study sites will include 10 community psychiatric
rehabilitation programs across urban and suburban
Maryland. Each location shares certain features: (1)
adult psychiatric rehabilitation day program with consu-
mers attending regularly at least 3 days a week; (2)
space for on-site physical activity classes; and (3) meals
served to consumers. The trial is enrolling men and
women, age 18 and older who are overweight (body
mass index ≥ 25.0 kg/m
2) or obese and attend the psy-
chiatric rehabilitation programs. By definition of their
psychiatric rehabilitation attendance, these participants
have a serious mental illness diagnosis. Persons with ser-
ious mental illness that receive care from rehabilitation
programs’ on-site mental health clinics are also eligible
for recruitment. The inclusion and exclusion criteria for
the trial are listed below.
Inclusion criteria
■ Age 18 and older;
■ Overweight, defined by Body Mass Index at least
25.0 kg/m
2;
■ Able and willing to give informed consent and parti-
cipate in the intervention;
■ On the same psychiatric medications within the 30
days before baseline weight (dose changes allowed;)
■ Able to attend at least 2 intervention sessions per
week (one weight management and one physical activity
session) during initial 6-month phase;
Exclusion criteria
■ Contraindication to weight loss
- Receiving active cancer treatment (radiation/
chemotherapy)
- Liver failure
- History of anorexia nervosa;
■ Cardiovascular event (unstable angina, myocardial
infarction) within previous 6 months;
■ Prior or planned bariatric surgery;
Use of prescription weight loss medication or over-
the-counter orlistat within 3 months
if participant does not agree to stop taking it;
■ Twenty pound or greater weight loss in 3 months
prior to baseline, as documented by staff measurement;
■ Inability to walk to participate in exercise class;
■ Pregnant or planning a pregnancy during study per-
iod. Nursing mothers would need approval from
physician;
■ Alcohol or substance use disorder either: 1) active
and determined to be incompatible with participation in
the intervention through discussion with program staff;
or 2) new abstinence from alcohol or substance use dis-
order in past 30 days;
■ Planning to leave rehabilitation center within
6 months or move out of geographic area within
18 months;
■ Investigator judgment (e.g., for concerns over safety,
adherence or follow-up);
■ Weight greater than 400 pounds.
Recruitment Strategies
Most recruitment activities occur on-site at the psychia-
tric rehabilitation centers and affiliated psychiatric
clinics. The primary means of recruitment is direct com-
munication with consumers. Regular mental health con-
sumer meetings at the rehabilitation programs provide
opportunities for study staff to present the study. During
presentations, study staff often show an informational
video and may incorporate an exercise class demonstra-
tion. Posters are displayed and fliers and brochures are
distributed. In addition, study staff make presentations
to rehabilitation program staff and outpatient mental
health clinic staff. Rehabilitation program staff and out-
patient clinic staff may mention the study to their cli-
ents. Potential participants also are identified by
working with rehabilitation staff and reviewing together
the list of rehabilitation program attendees, using a
HIPAA waiver. Study staff are available on-site at the
rehabilitation programs to discuss the study during the
times when consumers attend. Potential participants are
also given a phone number and a postcard to mail back
to reach study staff to indicate their interest.
To track recruitment, a roster of consumers attending
the center is provided by each rehabilitation program.
These rosters assist in defining and counting the num-
ber of consumers contacted and enable the characteriza-
tion of enrollees and non-enrollees.
Data Collection and Measurements
Before formal screening for the trial begins, oral consent
from rehabilitation center attendees is obtained and their
weight and height at study baseline is measured for cal-
culation of body mass index; weight will be measured
again at 6 and 18-month follow up data collection points.
Measuring weight of all consumers at the day program,
regardless of their interest in joining the weight loss
intervention study, allows for an understanding of: (1)
the natural history of weight gain in this population with-
out intervention and (2) how the environmental compo-
nent of the intervention (i.e., increasing options for
healthy meals on-site) may affect weight at the centers in
a pre/post fashion. The goal will be to measure height
and weight for as many attendees as possible.
For the formal trial, all participants provide written
informed consent using procedures reviewed and
approved by Johns Hopkins Institutional Review Boards
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consent obtained to conduct screening procedures and a
second consent obtained after baseline data collection
and prior to randomization. An evaluation of ability to
give consent is also administered for each participant
before screening consent which includes answering
questions about the goal of the study, what they will be
asked to do, and what risks may be involved if they join
the study. If a participant is deemed not able to give
consent, he/she may not join the study.
Participant eligibility is determined by the completion
of several screening measures. The Rose Angina Ques-
tionnaire and a checklist of medical conditions are
implemented to determine health status for a moderate
intensity exercise program [29]. If potential participants
h a v eap o s i t i v eR o s eQ u e s t i o n n a i r e ,ap r i o rh i s t o r yo f
cardiovascular disease or have diabetes mellitus, they
require an approval letter from their primary care physi-
cian in order to enroll in the study. In addition, primary
care physicians for all participants are contacted about
the study to ensure there are no contraindications to
weight loss or participation in moderate intensity physi-
cal activity. Alcohol and substance abuse are assessed
with the Addiction Severity Index-Lite [30]; medications
are reviewed; and plans to remain at the rehabilitation
center during the duration of the study to participate in
the trial are discussed with the consumer.
Data collection visits occur on-site at psychiatric reha-
bilitation centers and are conducted by trained data col-
lectors certified in study measures. Measurements are
conducted using standardized operating procedures and
quality control methods. Table 1 summarizes the data
collection measures and schedule. Follow-up measures
are collected at 6, 12, and 18 months after baseline.
Randomization and Blinding
After baseline data collection and before the interven-
tion begins, participants meet with study staff and the
intervention arms of the study are described in detail.
The study coordinator confirms that the participant
meets eligibility criteria, and that all required baseline
data have been collected. Participants interested in
enrollment are consented individually and randomized
to either the intervention or the control group. The
study coordinator ascertains and communicates treat-
ment assignments to participants [31]. Randomization is
stratified by gender and site using blocks of sizes 2 and
4 in random order to create the randomization sequence
for each stratum.
Due to the nature of the intervention, both partici-
pants and interventionists will be aware of the assign-
ment. The following mechanisms are in place for data
collection staff to be masked to treatment assignment:
1) designating and tracking unmasked study staff; 2)
excluding data collection staff from any part of interven-
tion delivery; 3) performing outcome assessments in
separate rooms than the intervention; and 4) reminding
participants not to share their group assignment. Until
the trial end, investigators, staff and participants are
masked to outcome data with the exception of the trial
statistician and data analyst. In addition, the primary
outcome variable, weight, is subject to very little mea-
surement bias [32].
Intervention
The ACHIEVE intervention incorporates concepts from
social cognitive theory, behavioral self-management and
the relapse prevention model [33-36]. The theoretical
base of the ACHIEVE Trial fits well within the psychia-
tric rehabilitation framework which emphasizes tenets of
intrinsic skills building and environmental supports
[37,38]. Motivational interviewing provides an important
framework for helping participants problem solve and
set goals for weight loss.
The ACHIEVE intervention operationalizes these
models by providing frequent and extended contacts,
opportunities for group interactions and social support,
goal setting and self-negotiation, problem solving, and
examples of new behavioral options. The intervention
was developed from a comprehensive lifestyle interven-
tion tested in the NHLBI sponsored PREMIER Trial (A
Trial of Lifestyle Interventions for Blood Pressure Con-
trol), which has proven efficacious for weight loss by
incorporating dietary and physical activity components
[16,19,39]. To the PREMIER foundation of individual
and group counseling sessions, on-site physical activity
sessions were added to take advantage of the psychiatric
rehabilitation environment as an opportunity for both
skills modeling and attaining most of the weekly recom-
mended physical activity. To further tailor the interven-
tion, the neurocognitive deficits in working memory,
verbal memory and executive function that are common
in persons with serious mental illness were addressed
[40,41]. Successful didactic interventions in schizophre-
nia emphasize learning a few, specific and narrow skills
repeatedly, breaking material into small units, learning
aides to reduce requirements on memory and attention,
repetition of content, and rehearsing behavioral skills
[42]. One successful approach for coping with cognitive
deficits is the use of compensatory environmental strate-
gies, which are adaptations in the environment designed
to bypass neurocognitive impairments and improve
adaptive functioning [43]; examples include signs, labels,
and devices designed to cue and sequence appropriate
behaviors and structure [44]. All aspects of the
ACHIEVE intervention were tailored to meet the
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Baseline 6 mo 12 mo 18 mo
For all rehabilitation enrollees:
Age, gender, race X
Height X
Weight XX X
For trial participants:
Sociodemographics (age, gender, race, ethnicity, marital status, education, employment, living arrangements) X X X
Medical history
Rose Angina Questionnaire [29] XX XX
Medical conditions XX X
Substance Use (Addiction Severity Index-Lite)[30] X
Mental health diagnoses (chart review) X
Medications XX XX
Physical measures
Height X
Weight XX XX
Submaximal bicycle ergometer XX X
Waist circumference XX X
Blood pressure-3 measures at each of 3 visits, 1 week apart X X X
Fasting serum measures
Glucose XX X
Insulin XX X
Lipids (total cholesterol, LDL, HDL, triglycerides) X X X
C-reactive protein XX X
Health behaviors
Block Diet Screeners [57,58] XX X
Direct observation of diet at rehabilitation centers X X X
Food preparation and shopping habits X X X
Physical Activity (International Physical Activity Questionnaire) [59] X X X
Tobacco smoking XX X
Mental health symptoms
Behavior and Symptom Identification Scale-24 [60] X X X
Center for Epidemiologic Studies Depression Scale [61] X X X
Health status-SF-12 [62]
Quality of life measures XX X
Euroqol EQ-D [63]
Impact of Weight on Quality of Life-Lite [64]
Social support measures
MOS Social Support Survey [65]
Social Support and Eating/Exercise (adapted) [66]
Self-efficacy measures
General Self Efficacy Scale [67]
Weight Efficacy Lifestyle Questionnaire [68]
Physical Activity Barriers Self-Efficacy Scale [69]
Other measures (binge eating, weight loss history, neighborhood characteristics, mobility, sleep quality) [70-73]
Safety measures XX X
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Table 2 outlines the cognitive adaptations in the
intervention.
The main intervention goals of ACHIEVE include: (1)
reducing caloric intake by avoiding sugar drinks and
“junk food,” (2) eating 5 fruits and vegetables a day, (3)
choosing smart portions and snacks, and (4) increasing
caloric expenditure through participation in 3 moderate
intensity aerobic exercise sessions per week at the psy-
chiatric rehabilitation program [10].
Table 3 reflects the ACHIEVE intervention character-
istics for participants randomized to the intervention
group. In the first individual session, the interventionist
begins a partnership with the participant and assesses
his/her readiness to change and understanding nutri-
tional principles. Behavior goals are set and in subse-
quent sessions the interventionist uses feedback and
motivational interviewing techniques to assess the parti-
cipant’s current progress and to help move towards the
next goal. These sessions allow the interventionist to tai-
lor the intervention to individual needs.
Group weight-management classes occur three times
per month during the intensive phase of the interven-
tion and each month the classes are focused on one
main topic, such as increasing fruit and vegetable con-
sumption. The sessions begin with a discussion to sup-
port and review the concepts discussed and practiced
since the prior session. A portion of the weekly session
is devoted to didactic information about healthy eating
or physical activity education, which is supported by
food models and posters, a self-monitoring worksheet,
hands-on activities related to the monthly topic, or food
tastings. Participants set individual behavioral goals
based on the material presented that week.
Group physical activity sessions are held three days
per week at the rehabilitation center (e.g., in a multipur-
pose area) and led by a trained exercise leader from the
study staff. A progressive exercise program starts at a
level appropriate for sedentary adults: 10-minute warm-
up; 10 minutes of moderate intensity physical activity
and 5-minute cool down [45]. The exercise duration
gradually increases each week until participants are
completing 40 minutes of moderate intensity physical
activity and 10 minutes of warm-up and cool-down. Par-
ticipants are encouraged to incorporate daily physical
activity outside of the group exercise class and may set
goals that reflect this effort.
In addition to the organized sessions, participants
meet with the intervention staff monthly for an indivi-
dual weight loss counseling session. This brief activity
provides immediate feedback on weight loss progress. If
participants lose weight, they are asked what worked for
them. If they gain weight, staff work to problem-solve
and assist in working towards a behavioral goal or set-
ting a more realistic goal.
Self-monitoring and positive reinforcement are impor-
tant aspects of successful weight loss trials. Participants
are asked to fill out a “Tracker” as a self-monitoring
tool outside of group sessions. Each tracker is used for
one week; participants record the number of servings of
fruits and vegetables, and respond yes or no to: exercis-
ing for 30 minutes; drinking sugar drinks; eating junk
food; smart portions or smart snacks. The Tracker pro-
vides a behavioral cue to participants. An incentive pro-
gram rewards participation in class and individual
sessions with choices of varying priced items (e.g., gym
suit, store gift card) after a specified number of stickers
have been earned. In order to earn a sticker in exercise
Table 2 Cognitive adaptations in the ACHIEVE intervention
Self-monitoring -Tracker: participants mark fruits/vegetables, sugar drinks, junk food, smart portions, smart snacks and exercise.
Detailed food and calorie log not required so complexity of recording is simplified.
-Weigh-in one time per week during the intensive phase, and once per month during the maintenance phase.
Frequent weigh-ins provide opportunity for reinforcement and repetition.
Group weight-management
sessions
-Highly structured, emphasis on behavioral rehearsal.
-Material taught in small content units. Frequent meetings (1 session per week during the intensive phase, 1 session
per month during the maintenance phase) allow repetition of concepts.
-Program materials are written at 5
th-8
th grade reading level.
-Hands-on activities emphasized. Taste testing, label reading, portion measuring.
- Role-playing emphasized. Practicing saying no to junk food, or choosing smarter portions at a birthday party.
Increases self-efficacy to adhere to healthier eating habits.
-Worksheets review topic of the week.
Individual sessions -Allow for individualized cognitive tailoring as needed.
-Opportunity to emphasize an individualized high impact behavior based upon the concepts learned in groups.
Physical activity classes -Provide opportunity for modeling and building physical activity skills in supportive setting to increase cardiovascular
fitness and exercise self efficacy
Environmental prompts -Refrigerator magnets, preprinted grocery lists, watches, water bottle, measuring cups, lunch bag as reminders to be
used at home.
Reinforcements -Participation is rewarded with varying levels of gifts relative to the number of classes attended.
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i nc l a s sf r o mt h ef i r s tm i n u t eo fw a r mu pt h r o u g ht h e
last minute of cool down. For weight management
group and individual visits, participants earn a sticker
for being present in class throughout the entire duration
of the session time.
For the maintenance intervention period, rehabilita-
tion center staff assumes the responsibility for much of
the exercise portion of the intervention in a stepped
process over two 6-month phases. Designated rehabilita-
tion center employees are trained by intervention study
staff and provided with exercise videos made by the
study team in an effort to mimic the instructor led exer-
cise class as much as possible. The rehabilitation staff
take responsibility for encouraging attendance and parti-
cipation, starting the video, overseeing the safety of the
class, and recording attendance data. Intervention study
staff are available for consultation as needed to offer
more support during this phase. This transition occurs
in order to facilitate the rehabilitation center’so w n e r -
ship of the program, with the goal of increasing the like-
lihood that the center will continue to offer components
of the intervention after the study is complete.
Intervention Delivery
ACHIEVE interventionists are skilled facilitators with
experience in behavior change and group and indivi-
dual-level counseling. Interventionists have a skill level
that would be typical for a community health educator
with a bachelor’s degree; exercise leaders have at least
one year of experience in leading an exercise class and/
or are a certified exercise instructor. Intervention staff
are trained to deliver any or all components of the inter-
vention in order to maximize the resources of this
multi-site trial. Manualized procedures and standardized
materials are used to ensure consistency of the
Table 3 Description of ACHIEVE Intervention
Initial Intervention (Months 1 through 6)
Type of contacts Frequency
Group weight-management class led by interventionist (45 min.) Once per week
3 of 4 weeks
Individual visit with interventionist (15-20 min.) Once per month
Group physical activity class led by exercise leader/interventionist (50 min.) Three times per week
Weigh-in during weight management group and individual visit (2 min.) Once per week
Maintenance Intervention (Months 7 through 12)
Type of contacts Frequency
Months 7 through 12 Months 13 through 18
Group weight management class
Overall frequency
Once per month Once per month
Led by interventionist Monthly Monthly
Individual visit with interventionist Every 4 weeks Every 4 weeks
Group physical activity class
Overall frequency
Three times per week Three times per week
Led by exercise leader/interventionist Twice per week Once per week
Monitored by rehab program staff Once per week Twice per week
Weigh-in
Overall frequency
Twice per month Twice per month
With intervention staff Twice per month Twice per month
Core Components
Self-monitoring Weigh-ins, Tracker food/exercise log
Goal setting, feedback, problem solving Motivational interviewing and support at group and individual
sessions
Social support Group and individual weight management sessions, group physical
activity sessions
Skills training Weight management group sessions, physical activity sessions,
individual sessions
Environmental supports Physical activity sessions, Staff education in health food choices on-
site
Environmental contingencies/reinforcements incentive items for attendance, participation and specific behaviors
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group exercise classes. Staff members are regularly
observed as part of ongoing staff training and fidelity
assurance.
Psychiatric rehabilitation program leadership and staff
at each site support the intervention and are involved in
the study on multiple levels. Program leadership from
each site work with the study team so that intervention
classes fit into the overall center schedule, and collabo-
rate on participants’ individual rehabilitation plans. Each
site designates at least one employee to become trained
to conduct group physical activity classes using an exer-
cise video.
Resources included in measuring the costs of the
intervention delivery include the number of staff, and
the duration of each activity. For each study site, staff
record one week of data at intervention months 2, 3, 5,
6, 12, 15 and 18. Staff time includes time with partici-
pants for intervention sessions, time spent preparing for
sessions, training and intervention-related meetings. All
research related activities are excluded from the cost
analysis.
Control Group
Participants in the control group receive standard nutri-
tion and physical activity written information at base-
line. Health classes are held quarterly for control
participants with content unrelated to weight loss (e.g.,
cancer screening, oral health).
Environmental Nutrition Intervention
In order to support intervention group participants’ abil-
ity to select healthy foods, interventionists provide con-
sulting services to rehabilitation program kitchen staff.
The consultation sessions help kitchen staff identify
healthier food choices for meals served on-site within
site budget and regulatory constraints (e.g., federal food
guidelines). Interventionists work with rehabilitation
staff to identify goals and then offer options to improve
food choices such reducing high sugar foods, working
on appropriate portion sizes and modifying vending
machine offerings. Rehabilitation staff choose goals and
which options they will incorporate.
A random sample of menus at baseline, 6 months, and
18 months are collected and evaluated for nutritional
content using ESHA software (The Food Processor,
2009, Salem, OR) [46].
Data Analysis
Randomly assigned intervention group (i.e., behavioral
intervention or control) is the main independent variable
for intent-to-treat analysis [47]. The co-primary out-
comes are weight loss at 6 and 18 months. To evaluate
the efficacy of the intervention for each of these
outcomes, generalized estimating equations are used
[48]. These models account for the longitudinal nature
of the trial and incorporate baseline, and 6, 12 and
18-month measurements and will account for study site
and other baseline characteristics found not to be
balanced by randomization. For secondary outcomes that
are categorical, logistic regression GEE models are used
according to the same principles outlined above for con-
tinuous outcomes.
In addition to the analyses that preserve the intention
to treat principle, analyses on subgroups defined post-
randomization are exploratory. These include analyses
in participants who attended the majority of weight
management and exercise intervention sessions.
Although second generation antipsychotics and other
psychotropic medications can induce substantial weight
gain [3,9], we expect that both study groups will be
equivalent in their distribution of these medication due
to the process of randomization. Several analytical
approaches are planned to address three main potential
effects of antipsychotic and other concomitant medica-
tion on study outcomes; these include: (1) imbalances in
medication use between the intervention and control
groups, despite randomization procedures, (2) variation
in intervention efficacy by medication or medication
class, and (3) changes in drug use after randomization.
The analytic approach to handle missing data will be
anchored on the assumption that data is missing at ran-
dom (MAR), where the probability of missing can
depend on all observed information such as measured
weights and covariates but does not depend on variables
that are not recorded. The analysis model will include
parameters for visit specific means for each treatment
group, baseline covariates associated with study reten-
tion, and use an unstructured covariance structure.
Missing at random is almost never strictly correct, but
careful modeling should make the missing data process
as close to MAR as possible. Primary analyses will be
conducted under the assumption of MAR; sensitivity
analyses will be based on sensible “missing not at ran-
dom” scenarios to evaluate the robustness of the infer-
ences under the MAR assumption.
For the environmental nutrition intervention, the
menus are collected at each data collection time point
and analyzed for nutrients using ESHA software. The
mean number of calories, macronutrients, and micronu-
trients at each site are determined and t-tests are used
to determine significant differences at each time point.
Given the expected variability between sites in making
changes to menus, differences in menu changes will be
assessed within each site and then overall.
To support the long-term goal to integrate the
ACHIEVE program into psychiatric rehabilitation cen-
ters, a cost analysis is planned. The primary analysis
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implementation from the perspective of a future payer
(e.g., Medicaid). A second analysis assesses costs from
the societal perspective projecting cardiovascular risk
factor changes 10 years into the future.
Sample size and power
The main objective of this trial is to detect weight loss
having public health significance. Previous work has
indicated that 4-5 pounds of weight loss should reduce
systolic blood pressure by ~3 mmHg, which has been
estimated to reduce stroke mortality by 6-8%; cardiovas-
cular heart disease mortality by 4-5%; and to reduce risk
of incident hypertension by 20% [18,49]. A Monte Carlo
simulation study was used to assess the power to detect
a clinically meaningful effect on weight loss at months 6
and 18 under a range of conservative assumptions about
the effect size, standard deviation, and follow-up with
potentially clustered sites [50]. It was assumed that a 4.5
lb difference in weight at 18 months between interven-
tion and control groups would be observed and that the
difference at 6 months would be larger. For power cal-
culations, we assumed a standard deviation of change in
weight of 12 lbs and that follow-up would be 80% com-
plete. Under these assumptions, for two-sided 0.05-level
tests of the null hypothesis, the study should provide
approximately 86% power for detecting a difference of
4.5 lbs with SD = 12 lbs. In addition, the study will have
the same power to detect the a similar effect size with a
smaller sample size if we achieve a higher follow-up
rate.
Discussion
Despite successful behavioral weight loss interventions in
the general population, few randomized controlled trials
of comprehensive behavioral weight loss interventions
among persons with serious mental illness have been per-
formed [51]. Given the high prevalence of obesity and
cardiovascular risk factors, effective weight loss programs
are needed in this vulnerable population. The ACHIEVE
investigators led a previous pilot weight loss study (n =
52) in two psychiatric rehabilitation programs and
demonstrated preliminary success with high levels of
recruitment, retention and pre/post weight loss of 4.8
pounds [52]. The ACHIEVE Trial will definitively test the
effectiveness of this innovative, practical intervention to
realize and sustain weight loss in overweight and obese
persons with serious mental illness. If successful, the
intervention will be a model program that should provide
important health benefits by reducing cardiovascular dis-
ease risk for persons with serious mental illness, and with
appropriate resources, could be disseminated widely.
This study compares the effectiveness of a multifa-
ceted weight loss intervention to a standard care group
among persons who often have cognitive impairments
and other comorbidities. Behavioral weight loss trials
have shown efficacy for weight loss in other populations.
For example, the ACHIEVE intervention was modeled
after the PREMIER Trial, a comprehensive lifestyle
intervention that incorporated education and counseling
for diet and physical activity; the trial was proven effec-
tive for weight loss in the general population [39]. The
Trial of Nonpharmacologic Intervention in the Elderly
(TONE) study demonstrated significant weight loss (3.5-
4.5 kg average reduction) among adults age 60-80 years
over a 30-month follow-up period [53]. Similarly, initial
1-year results from the Look AHEAD (Action for Health
in Diabetes) trial have shown that older adults (> 65
years) attend more lifestyle intervention sessions and
participate in more physical activity than their younger
counterparts [54]. At the end of a 6-month follow-up
period, participants in The Weight Loss Maintenance
trial demonstrated significant weight loss across racial
and gender groups; weight loss was greatest among
non-African American men and least among African
American women [55].
Although there have been few behavioral weight loss
intervention trials among persons with serious mental
illness, previous work suggests that short-term weight
loss can be achieved in this population [51,56]. The
magnitude of weight change in ACHIEVE and other
trials for persons with serious mental illness could be
lower than seen in other studies and populations. If
true, this may be due in part to participants having diffi-
culty incorporating targeted behaviors from weight man-
agement sessions or lacking resources to buy lower-
calorie foods. Other barriers to weight loss may include
persistent mental health symptoms and frequent hospi-
talizations. However, the ACHIEVE Trial is unique in
that interventionists provide frequent and extended con-
tacts at locations participants regularly attend. In con-
trast, previous lifestyle interventions in populations
without mental illness often have less frequent in-person
interaction and require participants to go to other loca-
tions for intervention groups and data collection. The
frequent contacts in a familiar setting in ACHIEVE may
help overcome barriers from cognitive limitations and/
or mental health symptoms and subsequently foster sig-
nificant weight loss. The multiple components of the
intervention are designed to include a variety of meth-
ods to induce behavior change through repetitive and
on-going activities (e.g., group and individual sessions,
rewards, food models, daily record trackers).
The ACHIEVE Trial is one of the first weight loss
trials that incorporates tailored weight management ses-
sions and on-site exercise classes to persons with serious
mental illness. This multi-site study will include a diver-
sity of racial/ethnic groups, suburban and urban areas
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with varying severity and types of psychiatric disease.
Thus, the results should be applicable to a wide range
of persons with serious mental illness.
O n ec h a l l e n g eo ft h eA C H I E V ET r i a li st h ee x t e n s i v e
support and buy-in from staff at the psychiatric rehabili-
tation centers required for success. ACHIEVE interven-
tionists and data collectors need the center’sp h y s i c a l
space and other resources such as time to consult with
staff in order to implement the intervention and collect
data. Even with enthusiasm from psychiatric rehabilita-
tion programs, intervention implementation may still be
challenging because of certain program constraints. In
the current funding environment, many mental health
programs are under significant financial stress and have
high staff turnover.
If the ACHIEVE intervention proves effective, there
will be strong justification for mechanisms to sustain
the program at current sites and disseminate it to other
centers. Resource data collected during the trial will
inform future costs of continuing the intervention. Prac-
tical considerations for intervention sustainability and
dissemination are complex and include how cardiovas-
cular disease prevention fits into centers’ priorities and
what funding the rehabilitation programs would have to
conduct the intervention. Centers likely would need
dedicated resources or reimbursement mechanisms to
contract with experienced interventionists and/or to
invest in training psychiatric rehabilitation staff to con-
duct appropriate intervention components.
The ACHIEVE Trial tests an evidence-based approach
to the problem of obesity in persons with serious mental
illness. The study will provide knowledge about how to
accomplish weight loss through an appropriately tailored
intervention delivered in a psychiatric rehabilitation set-
ting. Furthermore, the results from this study will
inform future work in healthy lifestyle interventions for
cardiovascular disease prevention in populations with
chronic mental illness.
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